- Home
- Publications
- Publication Search
- Publication Details
Title
AAV-Mediated Gene Therapy for Atherosclerosis
Authors
Keywords
Adeno-associated virus, Gene therapy, Atherosclerosis, Ischemic cardiomyopathy, Diabetes
Journal
Current Atherosclerosis Reports
Volume 16, Issue 9, Pages -
Publisher
Springer Nature
Online
2014-08-02
DOI
10.1007/s11883-014-0434-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations
- (2014) Ruchita Selot et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
- (2014) Jennifer G. Robinson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Severe Hypercholesterolemia Phenotype
- (2014) Allan D. Sniderman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Gene Transfer of Apolipoprotein A-V Improves the Hypertriglyceridemic Phenotype of apoa5 (−/−) mice
- (2013) Vineeta Sharma et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe−/− mice
- (2013) Mathias Burgmaier et al. ATHEROSCLEROSIS
- Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure
- (2013) Krisztina Zsebo et al. CIRCULATION RESEARCH
- Double-strand adeno-associated virus-mediated exendin-4 expression in salivary glands is efficient in a diabetic rat model
- (2013) Junhong Wang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Cardiovascular gene therapy for myocardial infarction
- (2013) Maria C Scimia et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Therapeutic expression of hairpins targeting apolipoprotein B100 induces phenotypic and transcriptome changes in murine liver
- (2013) P Maczuga et al. GENE THERAPY
- Gene therapy clinical trials worldwide to 2012 - an update
- (2013) Samantha L. Ginn et al. JOURNAL OF GENE MEDICINE
- Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk
- (2013) Gregory S. Thomas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
- (2013) Kevin Fitzgerald et al. LANCET
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic Delivery of shRNA by AAV9 Provides Highly Efficient Knockdown of Ubiquitously Expressed GFP in Mouse Heart, but Not Liver
- (2013) Bryan A. Piras et al. PLoS One
- Humoral Immune Response to AAV
- (2013) Roberto Calcedo et al. Frontiers in Immunology
- Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia
- (2012) Evan A. Stein et al. CIRCULATION
- Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
- (2012) D Gaudet et al. GENE THERAPY
- Adeno-Associated Virus Serotype 8 Gene Therapy Leads to Significant Lowering of Plasma Cholesterol Levels in Humanized Mouse Models of Homozygous and Heterozygous Familial Hypercholesterolemia
- (2012) Sadik H. Kassim et al. HUMAN GENE THERAPY
- Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy
- (2012) Mary P. McGowan et al. PLoS One
- Glucagon-Like Peptide-1 Gene Therapy
- (2011) Anne M. Rowzee et al. Experimental Diabetes Research
- Phase 2 Clinical Trial of a Recombinant Adeno-Associated Viral Vector Expressing α1-Antitrypsin: Interim Results
- (2011) Terence R. Flotte et al. HUMAN GENE THERAPY
- Apolipoprotein B Knockdown by AAV-delivered shRNA Lowers Plasma Cholesterol in Mice
- (2011) Annemart Koornneef et al. MOLECULAR THERAPY
- Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity
- (2011) Melissa Bartel Frontiers in Microbiology
- AAV/hSTAT3-gene delivery lowers aortic inflammatory cell infiltration in LDLR KO mice on high cholesterol
- (2010) Junaid A. Khan et al. ATHEROSCLEROSIS
- In Vivo Expression of HGF/NK1 and GLP-1 From dsAAV Vectors Enhances Pancreatic -Cell Proliferation and Improves Pathology in the db/db Mouse Model of Diabetes
- (2010) D. F. Gaddy et al. DIABETES
- AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency
- (2009) Stefan F. C. Vaessen et al. JOURNAL OF GENE MEDICINE
- Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses
- (2009) Roberto Calcedo et al. JOURNAL OF INFECTIOUS DISEASES
- Human Apolipoprotein E Expression from Mouse Skeletal Muscle by Electrotransfer of Nonviral DNA (Plasmid) and Pseudotyped Recombinant Adeno-Associated Virus (AAV2/7)
- (2008) Vanessa Evans et al. HUMAN GENE THERAPY
- Self-complementary AAV Vectors; Advances and Applications
- (2008) Douglas M McCarty MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More